Literature DB >> 17902044

Potential interaction between the GARS-AIRS-GART Gene and CP2/LBP-1c/LSF transcription factor in Down syndrome-related Alzheimer disease.

Disha Banerjee1, Krishnadas Nandagopal.   

Abstract

(1) GARS-AIRS-GART is an important candidate gene in studies of Down syndrome (DS)-related Alzheimer's disease (AD), due to its chromosomal localization (21q22.1) in the Down syndrome critical region, involvement in de novo purine biosynthesis, and over-expression in DS brain. The aim of this study was to identify factor(s) likely to enhance transcription of GARS-AIRS-GART in DS-related AD. (2) Based on a bio-informatics approach, the PromoterInspector, Promoter Scan II, and EBI toolbox CpG plot software programs were used to identify GARS-AIRS-GART sequences important for gene transcription. Transcription factor binding motifs within these regions were mapped with the help of the MatInspector and TFSEARCH programs. Factors implicated in neurodevelopment or neurodegeneration were the focus of attention, and mining of human (T1Dbase) and murine (GNF) expression databases revealed information on the regional distribution of these factors and their relative abundance vis-a-vis GARS-AIRS-GART. (3) The Leader-binding protein 1-c (LBP-1c/CP2/LSF) emerged as a promising candidate from these studies, as MatInspector and TFSEARCH analyses revealed a total of four CP2 binding sites with potential for functional interaction(s) within the promoter and CpG islands of GARS-AIRS-GART. Furthermore, two of these sites harbor sequences for methylation-sensitive restriction enzymes, which suggest that methylation status may, in part, regulate CP2-mediated transcription of GARS-AIRS-GART. A search of T1Dbase and GNF expression databases reveals co-expression of CP2 and GARS-AIRS-GART in brain regions relevant to DS-related AD. (4) The virtual screen identified CP2/LBP-1c/LSF as a factor that likely mediates enhanced transcription of GARS-AIRS-GART in DS-related AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17902044     DOI: 10.1007/s10571-007-9217-2

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  32 in total

Review 1.  Down syndrome and beta-amyloid deposition.

Authors:  Elizabeth Head; Ira T Lott
Journal:  Curr Opin Neurol       Date:  2004-04       Impact factor: 5.710

2.  Large-scale analysis of the human and mouse transcriptomes.

Authors:  Andrew I Su; Michael P Cooke; Keith A Ching; Yaron Hakak; John R Walker; Tim Wiltshire; Anthony P Orth; Raquel G Vega; Lisa M Sapinoso; Aziz Moqrich; Ardem Patapoutian; Garret M Hampton; Peter G Schultz; John B Hogenesch
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

3.  Cloning and expression of the human S100 beta gene.

Authors:  R J Allore; W C Friend; D O'Hanlon; K M Neilson; R Baumal; R J Dunn; A Marks
Journal:  J Biol Chem       Date:  1990-09-15       Impact factor: 5.157

4.  Predicting Pol II promoter sequences using transcription factor binding sites.

Authors:  D S Prestridge
Journal:  J Mol Biol       Date:  1995-06-23       Impact factor: 5.469

5.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.

Authors:  K Quandt; K Frech; H Karas; E Wingender; T Werner
Journal:  Nucleic Acids Res       Date:  1995-12-11       Impact factor: 16.971

6.  Characterization of the molecularly cloned murine alpha-globin transcription factor CP2.

Authors:  L C Lim; L Fang; S L Swendeman; M Sheffery
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

Review 7.  Trophic effects of purines in neurons and glial cells.

Authors:  M P Rathbone; P J Middlemiss; J W Gysbers; C Andrew; M A Herman; J K Reed; R Ciccarelli; P Di Iorio; F Caciagli
Journal:  Prog Neurobiol       Date:  1999-12       Impact factor: 11.685

8.  Molecular cloning of the alpha-globin transcription factor CP2.

Authors:  L C Lim; S L Swendeman; M Sheffery
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

9.  LBP-1c/CP2/LSF gene polymorphism and risk of sporadic Alzheimer's disease.

Authors:  F Panza; A D'Introno; A M Colacicco; C Capurso; A M Basile; F Torres; A Capurso; V Solfrizzi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-01       Impact factor: 10.154

10.  LSF and NTF-1 share a conserved DNA recognition motif yet require different oligomerization states to form a stable protein-DNA complex.

Authors:  M K Shirra; U Hansen
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

View more
  5 in total

1.  Phylogenetic analysis and in silico characterization of the GARS-AIRS-GART gene which codes for a tri-functional enzyme protein involved in de novo purine biosynthesis.

Authors:  Disha Banerjee; Krishnadas Nandagopal
Journal:  Mol Biotechnol       Date:  2009-03-20       Impact factor: 2.695

2.  MicroRNA-144 is regulated by CP2 and decreases COX-2 expression and PGE2 production in mouse ovarian granulosa cells.

Authors:  Jiawei Zhou; Bin Lei; Huanan Li; Lihua Zhu; Lei Wang; Hu Tao; Shuqi Mei; Fenge Li
Journal:  Cell Death Dis       Date:  2017-02-09       Impact factor: 8.469

3.  A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson's disease.

Authors:  Lining Su; Chunjie Wang; Chenqing Zheng; Huiping Wei; Xiaoqing Song
Journal:  BMC Med Genomics       Date:  2018-04-13       Impact factor: 3.063

4.  Proteomic analysis of lymphoblastoid cell lines from schizophrenic patients.

Authors:  Akira Yoshimi; Shinnosuke Yamada; Shohko Kunimoto; Branko Aleksic; Akihiro Hirakawa; Mitsuki Ohashi; Yurie Matsumoto; Kazuhiro Hada; Norimichi Itoh; Yuko Arioka; Hiroki Kimura; Itaru Kushima; Yukako Nakamura; Tomoko Shiino; Daisuke Mori; Satoshi Tanaka; Shuko Hamada; Yukihiro Noda; Taku Nagai; Kiyofumi Yamada; Norio Ozaki
Journal:  Transl Psychiatry       Date:  2019-04-22       Impact factor: 6.222

5.  Identification of differentially expressed genes and biological pathways in para-carcinoma tissues of HCC with different metastatic potentials.

Authors:  Yan Liu; Mingming Deng; Yimeng Wang; Huiqin Wang; Changping Li; Hao Wu
Journal:  Oncol Lett       Date:  2020-03-29       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.